| abstract |
The present invention relates to diabetes (type I and / or II), overweight, excessive food intake, metabolic syndrome, rheumatoid arthritis, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease, alcoholic fatty liver disease, osteoporosis, or osteoarthritis, poor Humanized calcitonin mimetics and their use in treating poorly controlled blood sugar levels, poorly controlled responses to glucose loading tests, or poor control of food intake. |